Media Pack
News

Current Edition

Volume 16 Issue 2
 
Regional News

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Homegrown mRNA players BioNTech and CureVac have signed on to supply Germany with vaccines against future health emergencies for years to come. Germany will pay u...
17 March 2022 Regional News BioNTech | CureVac
Continue Reading →
Regional News

Pfizer, ex-employee reach a deal in COVID-19 vaccine trade secrets case

A now-former Pfizer employee is playing nice after the drugmaker sued her in November alleging the 15-year veteran uploaded more than 12,000 sensitive files—including...
13 December 2021 Regional News BioNTech | Comirnaty
Continue Reading →
Regional News

Pfizer, BioNTech say omicron partially evades its COVID vaccine but booster can restore protection

The COVID-19 vaccine produced by Pfizer and BioNTech, Comirnaty, provides less protection against the omicron variant than it did against wild-type COVID and other va...
10 December 2021 Regional News BioNTech | booster
Continue Reading →
Regional News

Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant

As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and vaccines have warned that their current offerin...
1 December 2021 Regional News BioNTech | COVID-19
Continue Reading →
Regional News

AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his company’s shot offers longer-lasting protection

AstraZeneca’s chief executive Pascal Soriot is challenging the notion that his company's vaccine is inferior to the mRNA vaccines from Moderna and Pfizer. In fact, h...
24 November 2021 Regional News AstraZeneca | BioNTech
Continue Reading →
Regional News

Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine

The COVID-19 pandemic is creating a $100 billion pharma goliath. Pfizer’s revenue could reach $101.3 billion in 2022, with major contributions coming from the compan...
24 November 2021 Regional News antiviral | BioNTech
Continue Reading →
Regional News

As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster use

Like its partner on its COVID-19 vaccine, BioNTech keeps upping its estimate for 2021 vaccine revenue. Last week, Pfizer jacked up its annual guidance on its vaccine ...
10 November 2021 Regional News BioNTech | COVID-19
Continue Reading →
Regional News

What would Medicare price negotiations bring to the US? Look to Europe, Lilly CEO Ricks says

When posed with the decades-old question of how drug price reform would affect their operations in the U.S., pharma execs have a ready-made response: Reducing drug pr...
26 October 2021 Regional News BioNTech | biotech
Continue Reading →
Regional News

BioNTech, eyeing $18B-plus in COVID-19 vaccine sales this year, poised to join the ranks of the world’s top drugmakers

The COVID-19 pandemic helped put mRNA vaccines on the map. Now, thanks to the shots' quick uptake in rich countries, mRNA specialist BioNTech appears poised to join t...
10 August 2021 Regional News BioNTech | coronavirus
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte